Cite
HARVARD Citation
Sadushi-Kolici, R. et al. (2019). Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial. Lancet. 7 (3), pp. 239-248. [Online].